Digital wealth manager Moneyfarm secures £36 million in Series C funding
IP, divestments, fragmentation and the future: M&A in life sciences
Biosimilars – Clearing the way for launch
Patents diary: September 2019
Dr Bill Frankland: Penicillin, the pollen count and perspectives on medicine
Arbitration considerations for life science companies
Synapse - September 2019
Regulatory capital instruments: update to PIN requirements for CRR firms
Children and personal data